Glooko

Glooko offers comprehensive connected care solutions for diabetes and related chronic conditions, catering to providers, clinical researchers, patients, payers, and partners. With a global presence and localized websites in Germany, Spain, and France, Glooko supports remote patient management and personalized diabetes care. The platform enables healthcare providers to utilize approved CPT codes for remote monitoring, integrates with top EHR systems to streamline workflows, and is trusted by providers and patients in over 30 countries and 8,000+ clinics. Glooko’s solutions deliver improved health outcomes within three months, with sustained results after one year. The company supports over 200 diabetes devices for data synchronization and offers a Mobile Insulin Dosing System (MIDS) for optimizing insulin doses. Glooko collaborates with Sanofi for SoloStar Pen Connectivity and partners with Hedia for insulin dosing algorithm integration. The company is committed to exceeding data security, quality, and compliance expectations, holding ISO 27001, SOC 2 Type I and II, and HITRUST certifications. Glooko also engages in clinical research, providing real-world data and supporting connected clinical trials. The platform includes a Knowledge Hub with resources like videos, case studies, and brochures, and engages in corporate social responsibility initiatives to reduce health disparities. Glooko offers a free mobile app for patients to sync data from various diabetes devices and collaborate with their care team.